1. AB0160 Effects of TOFACITINIB (CP-690, 550) on lipid biomarkers in rat adjuvant-induced arthritis (AIA) model and in patients with active rheumatoid arthritis. (23rd January 2014) Authors: McInnes, I.; Kaplan, I.; Boy, M.; Riese, R.; Zuckerman, A.; Clark, J.; Kishore, N.; Brosnan, M.; Zwillich, S.; Bradley, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0595 Changes in serum creatinine in patients with active rheumatoid arthritis treated with TOFACITINIB (CP-690, 550). (23rd January 2014) Authors: Isaacs, J.; Nduaka, C.; Zuckerman, A.; Krishnaswami, S.; Riese, R.; Lan, S.; Hutmacher, M.; Boy, M.; Bradley, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0137 Effects of tofacitinib on lipid biomarkers in patients with active rheumatoid arthritis. (23rd January 2014) Authors: McInnes, I. B.; Kaplan, I.; Boy, M.; Riese, R.; Zuckerman, A.; Gruben, D.; Brosnan, M. J.; Zwillich, S.; Bradley, J. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0126 Evaluation of the Effect of Tofacitinib on Measured Glomerular Filtration Rate in Patients with Active Rheumatoid Arthritis. (10th June 2014) Authors: Kremer, J.; Kivitz, A.; Simon-Campos, J.; Nasanov, E.; Tony, H.; Vlahos, B.; Hammond, C.; Bukowski, J.; Li, H.; Schulman, S.; Raber, S.; Zuckerman, A.; Isaacs, J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗